Effect of Metabolic Syndrome Status on Lung Function and Patient- reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Indacaterol/Glycopyrrolate: Co-morbidity Analysis of the Phase 3 FLIGHT1 and 2 Studies

被引：0

作者：

Carlin, Brian ^{[1
]}

Ferguson, Gary T. ^{[2
]}

Sanjar, Shahin ^{[3
]}

Sharma, Sanjay ^{[3
]}

Ozol-Godfrey, Ayca ^{[3
]}

Goodin, Thomas ^{[3
]}

机构：

[1] Sleep Med & Lung Hlth Consultants, Ingomar, PA USA

[2] Pulm Rsch Inst Southeast Michigan, Dept Med, Farmington Hills, MI USA

[3] Sunov Pharmaceut Inc, Med Affairs, Marlborough, MA USA

来源：

CIRCULATION | 2018年 / 138卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A14734

引用

页数：2

共 14 条

[1] Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Smoking Status: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies
Sanjar, S.
Goodin, T.
Bowling, A.
Price, B.
Ozol-Godfrey, A.
Sharma, S.
Tashkin, D. P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[2] Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Reversibility: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies
Sharma, S.
Goodin, T.
Bowling, A.
Price, B.
Ozol-Godfrey, A.
Sanjar, S.
Ohar, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[3] Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol/glycopyrrolate: Pooled analysis of the FLIGHT1 and FLIGHT2 studies
Tashkin, Donald P.
Goodin, Thomas
Bowling, Alyssa
Price, Barry
Ozol-Godfrey, Ayca
Sharma, Sanjay
Sanjar, Shahin
RESPIRATORY MEDICINE, 2019, 155 : 113 - 120
[4] The Effect of Metabolic Syndrome Status on Lung Function and Patient-reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
Carlin, Brian
Ferguson, Gary T.
Ozol-Godfrey, Ayca
Goodin, Thomas
Sanjar, Shahin
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2020, 7 (04):
[5] Effect of Metabolic Syndrome Status on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies
Carlin, B.
Ferguson, G. T.
Ozol-Godfrey, A.
Goodin, T.
Sanjar, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[6] Improvement In Lung Function With Indacaterol/glycopyrrolate (ind/gly) In Patients With Moderate To Severe COPD From The Us: A Subgroup Analysis From The Flight1 And Flight2 Studies
Kerwin, E.
Mahler, D. A.
FowlerTaylor, A.
Maitra, S.
Banerji, D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[7] Improvement in Lung Function and Patient-Reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies
Hanania, N. A.
Ozol-Godfrey, A.
Tocco, M.
Goodin, T.
Sanjar, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[8] Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies
Ohar, J. A.
Ozol-Godfrey, A.
Goodin, T.
Sanjar, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[9] Lung Function and Patient-Reported Outcomes Response to Glycopyrrolate (SEEBRI™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Reversibility: Pooled Analysis of the GEM1 and GEM2 Studies
Bowling, A.
Goodin, T.
Price, B.
Ozol-Godfrey, A.
Sharma, S.
Sanjar, S.
Ohar, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[10] Indacaterol/glycopyrrolate Improves Lung Function, Dyspnea And Health Status In Symptomatic Patients With COPD Using Prior Lama, Laba Or Laba/ics: Post-Hoc Analysis From Pooled Flight1 And Flight2 Studies
Ayers, T.
Maitra, S.
Fogel, R.
Banerji, D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193

← 1 2 →